# Intraperitoneal Lidocaine in Ovarian Cancer Surgery

> **NCT05450055** · NA · NOT_YET_RECRUITING · sponsor: **Peking University Third Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Ovarian Cancer
- Post Operative Pain

## Interventions

- **PROCEDURE:** intraperitoneal lidocaine analgesic or normal saline as control

## Key facts

- **NCT ID:** NCT05450055
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-07-18
- **Primary completion:** 2024-07-30
- **Final completion:** 2029-07-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05450055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05450055, "Intraperitoneal Lidocaine in Ovarian Cancer Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05450055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*